FFG
JAZZ icon

Fiduciary Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fiduciary Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,432
Closed -$248K – 309
2025
Q1 		$248K Sell
2,432
-142
-6% -$18.5K 0.05% 232
2024
Q4 		$313K Buy
2,574
+18
+0.7% +$2.12K 0.07% 181
2024
Q3 		$275K Buy
2,556
+279
+12% +$30.6K 0.06% 218
2024
Q2 		$242K Buy
+2,277
New +$250K 0.06% 227

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Fiduciary Financial Group's JAZZ Position: Q2 2025 in Review

Fiduciary Financial Group sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 2,432 shares — an estimated $248K sold.

Fiduciary Financial Group first reported a position in JAZZ in Q2 2024 and held it in 4 quarters. The position peaked at $313K in Q4 2024. 501 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Fiduciary Financial Group reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Fiduciary Financial Group sold 2,432 Jazz Pharmaceuticals shares in Q2 2025, an estimated $248K.
  • Fiduciary Financial Group first reported a position in Jazz Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Fiduciary Financial Group's Jazz Pharmaceuticals position peaked at $313K in Q4 2024.
  • 501 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Fiduciary Financial Group's 13F filing for Q2 2025, filed 3 Jul 2025.